Interaction of Blood Pressure and Glycemic Status in Developing Cardiovascular Disease: Analysis of a Nationwide
Yuta Suzuki1,2, Hidehiro Kaneko1,3, Yuichiro Yano4,5
1The Department of Cardiovascular Medicine The University of Tokyo Tokyo Japan.
Insights
Hypertension and hyperglycemia additively increase cardiovascular disease risk. However, their individual contributions diminish as the other condition worsens, indicating a complex interaction.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Hypertension and diabetes often coexist, but their combined impact on cardiovascular disease (CVD) development is not fully understood.
- Existing research has limited insight into the interaction between elevated blood pressure (BP) and hyperglycemia in CVD pathogenesis.
Purpose of the Study:
- To investigate the additive and interactive effects of hypertension and hyperglycemia on the risk of developing various cardiovascular events.
- To quantify how worsening glycemic status affects hypertension-related CVD risk and how increasing BP affects hyperglycemia-related CVD risk.
Main Methods:
- An observational cohort study involving 3,336,363 patients without prior CVD or use of BP/glucose-lowering medications.
- Categorization of hypertension (Stage 1 and Stage 2) and glycemic status (normal, prediabetes, diabetes) based on defined BP and fasting plasma glucose levels.
- Analysis of the incidence of myocardial infarction, angina pectoris, stroke, heart failure, and atrial fibrillation over a mean follow-up of approximately 3.25 years.
Main Results:
- Both elevated BP and hyperglycemia independently and additively increased the risk of all studied cardiovascular events.
- The relative risk of hypertension-related CVD decreased as glycemic status worsened (e.g., Stage 2 hypertension showed reduced heart failure risk with prediabetes and diabetes compared to normal glucose levels).
- The relative risk of hyperglycemia-related CVD attenuated as BP increased (e.g., diabetes showed reduced CVD risk with increasing BP categories).
Conclusions:
- Hypertension and hyperglycemia act additively to elevate cardiovascular disease risk.
- A significant interaction exists where the relative contribution of hypertension to CVD risk decreases with worsening hyperglycemia, and vice versa.
- These findings highlight the complex interplay between blood pressure and glucose metabolism in cardiovascular health.
Abstract:
Background Hypertension and diabetes frequently coexist. However, little is known about the interaction between high blood pressure (BP) and hyperglycemia in the development of cardiovascular disease (CVD). Methods and Results We conducted an observational cohort study that included 3 336 363 patients (median age, 43 years old; men, 57.2%). People taking BP- or glucose-lowering medications or those with prior history of CVD were excluded. We defined stage 1 hypertension as having systolic BP of 130 to 139 mm Hg or diastolic BP of 80 to 89 mm Hg and stage 2 hypertension as having systolic BP of ≥140 mm Hg or diastolic BP of ≥90 mm Hg. We defined prediabetes as having fasting plasma glucose of 100 to 125 mg/dL and diabetes as having fasting plasma glucose of ≥126 mg/dL. Over a mean follow-up period of 1185 ± 942 days, 5665 myocardial infarction, 52 475 angina pectoris, 25 436 stroke, 54 508 heart failure, and 12 932 atrial fibrillation events occurred. The BP and fasting plasma glucose categories additively increased the risk of myocardial infarction, angina pectoris, stroke, heart failure, and atrial fibrillation. However, the relative risk of stage 1 and stage 2 hypertension developing into CVD was attenuated with deteriorating glycemic status. Similarly, the relative risk of prediabetes and diabetes developing into CVD was attenuated with increasing BP. For example, the relative risk reduction of stage 2 hypertension for heart failure was 53.5% in individuals with normal fasting plasma glucose, 46.4% in those with prediabetes, and 37.2% in those with diabetes. The robustness of our findings was confirmed using a multitude of sensitivity analyses. Conclusions Although hypertension and hyperglycemia additively increase the risk of developing CVD, the relative contribution of hypertension to the development of CVD decreased with deteriorating glycemic status and that of hyperglycemia was attenuated with increasing BP. Our results indicate a potential interaction between hypertension and hyperglycemia in the development of CVD.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Factors affecting Blood pressure
Physiological Factors:
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Errors occurring during blood pressure monitoring
Several factors...
Hypertension II: Pathophysiology


